AMD Resource Center - Eyetube

AMD Resource Center

This resource center is
supported with advertising by


Featured AMD Video



Monitoring Patients at Home With SPARCS

Jesse Richman, MD

Updates from the ALTAIR Study

Gemmy Cheung, MD

Clinical Changes in RPE Atrophy: Case Report (Part Two)

Ameen Marashi, MD

Clinical Changes in RPE Course: PED in Non-AMD Cases

Ameen Marashi, MD

Takeaways From New STAIRWAY Study Data

Arshad Khanani, MD

Take-Home Points for APL-2

David S. Boyer, MD

Anatomy in HAWK and HARRIER

Pravin U. Dugel, MD

Understanding the ALTAIR Study

Masahito Ohji, MD

Three Exciting New Drugs

Pravin U. Dugel, MD

Is There Any Hope for Dry AMD Patients?

Anat Loewenstein, MD, William Tucker, MD

Quarterly Dosing and AMD: A Cross-Trial Comparison

David A. Eichenbaum, MD

AMD Update

Steven G. Ferrucci, OD, FAAO

Subretinal TPA

Janelle Adeniran, MD, Charles C. Barr, MD

Subretinal TPA

Charles C. Barr, MD

Sirolimus for Chronic AMD

Raj Maturi, MD

A New Surgical Approach to Managing Dry AMD

Bobby Qureshi, BSc, MBBS, FRCS Ophth

Potential Treatments for AMD

Thomas Ciulla, MD

Displacement of Subfoveal Hemorrhage by Perfluorocarbon

Gurkan Erdogan, MD

100th Argus II Retina Prosthesis Implant - Part 5

Stanislao Rizzo MD

100th Argus II Retina Prosthesis Implant - Part 4

Stanislao Rizzo MD

100th Argus II Retina Prosthesis Implant - Part 3

Stanislao Rizzo MD

100th Argus II Retina Prosthesis Implant - Part 2

Stanislao Rizzo MD

100th Argus II Retina Prosthesis Implant - Part 1

Stanislao Rizzo MD

UK's Leading Blindness Organizations Meet to Address Macular Degeneration

Intraocular Miniature Telescope Lens

Howard Gimbel MD

Genetic Testing and AMD

Michael Cooper, OD, Steven Ferrucci, OD

Lower the Burden: Two-Year Efficacy of Stereotactic Radiotherapy for the Treatment of Wet AMD

Darius Moshfeghi, MD

Screening Patients and Treating with Oraya Therapy

Andre Luff, MA, FRCS, FRCS (Ophth), FRCOphth

Not What You Expect: Identifying and Assessing Microvascular Abnormalities Following Oraya Therapy

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD

Clinical Experience with Intravitreal Aflibercept for Wet AMD

Arshad M. Khanani, MD

Genetic Polymorphisms Predict Response to Antioxidants and Zinc in Patients with AMD

Carl C. Awh, MD

Latest Observations on Wide-Field Imaging of Retinal Diseases

Szilard Kiss, MD, Timothy G. Murray MD, MBA, FACS

Nothing in Vein: the Evolving Management of Retinal Venous Occlusive Disease

Julia Haller MD, Timothy G. Murray MD, MBA, FACS

Anti-VEGF Maintenance Therapy for Neovascular AMD

Carl Regillo, MD, Timothy G. Murray MD, MBA, FACS

Systemic Levels of Anti-VEGF: What Available Data Reveal

Robert Avery MD, PhD


Barbara Parolini, MD

A Clinical Understanding of Anti-VEGF Therapy in AMD

Richard Spaide, MD

Two-Year Outcomes in the IVAN Trial

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD

Results of the AREDS 2 Study

SriniVas Sadda, MD

Effects of Switching AMD Patients to Aflibercept

Ted Leng, MD

HARBOR 2 Results Support Individualized Dosing in Patients with wAMD

Brandon G. Busbee, MD

Implantation of Intraocular Mirror Telescope Implant as Anterior Segment Surgical Treatment for Dry and Wet AMD Eyes

Isaac Lipshitz, MD

Are multifocal IOLs contraindicated in AMD?

Jean-François Korobelnik, MD

Resource Center Articles

A multipart case series presented by experts in the management and treatment of wet age-related macular degeneration.

Retina Today Articles on AMD

Retina Today May/June 2019

Emerging Treatments for Neovascular AMD

Natalie Huang, MD; and Patrick Oellers, MD

Novel treatment options hold the promise of longer-term VEGF suppression.

Retina Today May/June 2019

Gene Therapy Trials for Wet Age-Related Macular Degeneration

Allen C. Ho, MD; and Robert L. Avery, MD

After a series of failed trials, hope is on the horizon for the viability of gene therapy for wet AMD.

Retina Today May/June 2019

Sustained Suppression of VEGF: Looking Forward and Looking Back

Peter A. Campochiaro, MD

The results of the LADDER trial demonstrate a major step forward but introduce many questions.

Retina Today March 2019

Retina News

Retina Today January/February 2019

Acupuncture for Dry AMD

Deepinder K. Dhaliwal, MD, LAc; and Siwei Zhou, MD

Research suggests that this branch of complementary medicine may hold promise.

Retina Today November/December 2018

The Next Frontier of Disease Monitoring and Management?

Judy E. Kim, MD

How home-based telemedicine could be transformational for patients with AMD.

Retina Today November/December 2018

A Review of All Things Retina

Michele Corry

Looking back at some of the field’s exciting developments over the past 12 months.

Retina Today May/June 2018

Is Macular Degeneration Slowly Going Away?

Brian C. Joondeph, MD, MPS

What studies say, why this may be, and what it means.

Retina Today May/June 2018

Involving Patients in the Care of Their AMD

Nancy M. Holekamp, MD

A typical week in the life of this retina specialist shows that the future of home monitoring is now.

Retina Today May/June 2018

In Pursuit of an Earlier Diagnosis

Allen C. Ho, MD

Home monitoring can help detect wet AMD earlier to reduce the time between disease onset and initiation of treatment.

Retina Today May/June 2018

Spread the Word

Alan Mendelsohn, MD

Retina specialists who educate patients about the dangers of smoking can help prevent ocular damage.

Retina Today May/June 2018

Pharmacogenomics and Age-Related Macular Degeneration

Demetrios G. Vavvas, MD, PhD

Controversy over the links between supplementation, genomics, and treatment response may have been due to researchers asking the wrong question.

Retina Today March 2018

Teleophthalmology Travels Great Distances in Canada

Parampal S. Grewal, MD; Uriel Rubin, MD; Christopher J. Rudnisky, MD, MPH, FRCSC; and Matthew T.S. Tennant, MD, FRCSC

Telemedicine programs bring ophthalmic care to remote populations and others who lack access.

Retina Today November/December 2017

Retina News

Retina Today November/December 2017

The Lowdown on Fluorescence Lifetime Imaging Ophthalmoscopy

Chantal Dysli, MD, PhD; Sebastian Wolf, MD, PhD; and Martin S. Zinkernagel, MD, PhD

A novel mode of diagnostic imaging provides new information about retinal diseases.

Retina Today October 2017

Retina News

Retina Today October 2017

Case Report: Combined Central Retinal Artery and Vein Occlusion After Anti-VEGF Injection

Ferdinand Rodriguez, MD; Joshua D. Levinson, MD; and Jordana G. Fein, MD, MS

A patient with a history of peripheral vascular disease may have been at increased risk for this complication.

Retina Today September 2017

Retina News

Retina Today July/August 2017

Each Issue a Recipe

Allen C. Ho, MD, and Robert L. Avery, MD

Retina Today July/August 2017

Retina News

Retina Today May/June 2017

Putting Vision Monitoring in the Hands of Patients With AMD

S.K. Steven Houston III, MD

The future is remote. Embrace it.

Retina Today May/June 2017

Buyer Beware: Ignorance ≠ Bliss

Zubair A. Ansari, MD; Ajay E. Kuriyan, MD, MS; Thomas A. Albini, MD; and Harry W. Flynn Jr, MD

Unregulated stem cell clinics pose real risks to patients with AMD.

Retina Today May/June 2017


Karen Roman, Editor-in-Chief

Retina Today May/June 2017

Predicting Geographic Atrophy Growth With SD-OCT

Theodore Leng, MD, MS

The ability to identify ideal treatment candidates could speed clinical trials.

Retina Today May/June 2017

Mitochondrial Genetics in AMD

M. Cristina Kenney, MD, PhD, and Baruch D. Kuppermann, MD, PhD

The powerhouse of the cell holds potential for the treatment of age-related disease.

Retina Today May/June 2017

Science and Medicine Make for a Better Tomorrow

Allen C. Ho, MD, and Robert L. Avery, MD

Retina Today April 2017

Retina News

Retina Today January/February 2017

Looking Forward and Looking Backward

Sundeep K. Kasi, MD

Presenters at the Wills Retina Update asked retina doctors to look to the past to treat some patients while also exploring how future innovations could change the field’s dynamics.

Retina Today January/February 2017

Tie Fighters

Aron Shapiro; David Hollander, MD; and Lisa Smith

Targeting Tie-2 in patients with wet AMD or diabetic eye disease could allow clinicians to treat patients who have not responded to conventional therapies.

Retina Today November/December 2016

Targeting the Visual Cycle: Dry AMD and Stargardt Disease

Aron Shapiro; David Hollander, MD, MBA; and Andrew Hertsenberg, PhD

The visual cycle could be the crucible for treating two important degenerative eye diseases.

Retina Today November/December 2016

Recapping the Past 12 Months

the staff of Retina Today

Retina Today October 2016

Gene Therapy in a Drop

Kuan Jiang and Gang Wei, PhD, with editorial commentary from Szilárd Kiss, MD

The lowdown on an investigational, noninvasive gene delivery system for the treatment of retinal disease.

Retina Today September 2016

Drug Delivery to the Retina

Timothy W. Olsen, MD

Questions, thoughts, and opinions related to current and emerging drug delivery systems.

Retina Today September 2016

A Team-Based Approach to Treating Advanced Macular Degeneration

Sundeep K. Kasi, MD, and Carl D. Regillo, MD

The combination of candidate selection, occupational therapy, and Implantable Miniature Telescope surgery is not a one-person job.

Retina Today July/August 2016

CATT 5-Year Data: Our Perspective

Allen C. Ho, MD, and Robert L. Avery, MD

Retina Today July/August 2016

The Promise of Integrin Receptors for Treating Vitreoretinal Disorders

Victor H. Gonzalez, MD

Study results suggest this class of drug has vitreolytic activity and a longer duration of effect than current treatments.

Retina Today July/August 2016

An Oral Drug for Treatment of AMD?

Carl C. Awh, MD

The potential for this proposed treatment option could be significant for many patients and their caregivers.

Retina Today July/August 2016

Improving Outcomes in Neovascular AMD With Combination Intravitreal Therapy

Jeffrey S. Heier, MD

Could an anti-PDGF drug work with an anti-VEGF agent to provide better antiangiogenic effect than anti-VEGF monotherapy?

Retina Today July/August 2016

Combination Therapy for Neovascular AMD

Glenn J. Jaffe, MD

Could the combination of an anti-VEGF agent and an anti-PDGF drug solve some of the issues seen with anti-VEGF monotherapy? Trial data may soon tell.

Retina Today July/August 2016

Other Anti-VEGF/Anti-PDGF Combination Drugs in the Pipeline for Treatment of AMD

the staff of Retina Today

Retina Today May/June 2016


Retina Today May/June 2016

Advances in Therapy for Dry AMD

Aron Shapiro

Numerous approaches to treatment of dry AMD are under development.

Cataract & Refractive Surgery Today March 2016

Implantable Miniature Telescope Offers Hope to Patients With Advanced AMD

Mark S. Milner, MD

A viable option for patients with severe vision loss.

Cataract & Refractive Surgery Today Europe March 2016

Recognizing the Patient at Risk for Depression After Vision Loss

Khadija S. Shahid, OD, FAAO

Depression may be a necessary step in adjusting to an impairment.

Cataract & Refractive Surgery Today Europe March 2016

Across the Pond

Tidbits from what your US colleagues are reading in CRST.

Retina Today January/February 2016


Retina Today November/December 2015

Medical Necessity for AMD Diagnostic Testing

Riva Lee Asbell

Tips on billing for OCT and fundus photography.

Glaucoma Today November/December 2015

The Literature

Paul Lee, MD

Retina Today September 2015

Drug Delivery to the Posterior Segment

Daniel D. Esmaili, MD; and David S. Boyer, MD

A review of methods and technologies available and those on the horizon.

Cataract & Refractive Surgery Today Europe September 2015

Where Circadian Rhythms and IOL Technology Merge

Francis Ferrari, MD

The éclipse lens helps maintain patients’ circadian rhythms and blocks harmful blue light.

Cataract & Refractive Surgery Today Europe September 2015

Ones to Watch: Premium IOL Technologies

Jorge L. Alió, MD, PhD, FEBO

These lenses represent areas of major and expanding interest for ophthalmology and the industry.

Retina Today July/August 2015

A New Self-Testing System for Patients With AMD or DME

Raj K. Maturi, MD

Changing treatment patterns often dictate the need for a change in disease detection.

Retina Today July/August 2015

SD-OCT Imaging in Eyes Implanted With a Miniature Telescope

Anna Pappas, BS, COA; Melanie J. Fortin, BS, COA; and Brian C. Joondeph, MD, MPS

Overcoming imaging challenges in eyes of AMD patients implanted with a telescope can result in high-quality images.

Retina Today July/August 2015

A Dual-Mechanism Drug for Vitreoretinal Diseases

Baruch D. Kuppermann, MD, PhD

With two distinct mechanisms of action, a new anti-integrin drug may be able to treat multiple targets across a range of conditions.

Retina Today July/August 2015

Profile of a Potential Treatment for Geographic Atrophy

Karen Roman, Editor-in-Chief

An in-depth look at a complement-targeted therapy.

Retina Today July/August 2015

Another Anti-VEGF Agent for Treatment of Neovascular AMD

Xiaoxin Li, MD, PhD; Xiaoyan Ding, MD, PhD; and Peter K. Kaiser, MD

If approved by the FDA, a new anti-VEGF agent could provide physicians with an alternative treatment for neovascular AMD.

Retina Today May/June 2015

Early Detection of Choroidal Neovascularization Using Home Monitoring

Allen C. Ho, MD

Raising the standard for at-home monitoring can help us help our patients save their vision.

Retina Today May/June 2015

Using SD-OCT Biomarkers and Big Data Analyses to Identify Eyes at Risk for AMD Progression

Theodore Leng, MD, MS

New imaging algorithms and a statistical risk assessment model may be beneficial for earlier identification and treatment of eyes with AMD.

Retina Today May/June 2015

OCT Angiography in Age-Related Macular Degeneration

Laura Kuehlewein, MD; David Sarraf, MD; and SriniVas R. Sadda, MD

Retina Today May/June 2015

Long-Lasting Effects of Combination Anti-VEGF and Photodynamic Therapy in the Treatment of Exudative AMD

Kent W. Small, MD; Fadi Shaya, BS; Rosemary Silva-Garcia, MD; and Colleen McLellan, BS

A retrospective chart review of cases suggests a rationale for combination therapy in patients with age-related macular degeneration.

Retina Today May/June 2015

Injecting and Imaging Patients With Wet AMD and Implanted Telescopes

Jon Zick and Brian C. Joondeph, MD, MPS

Physicians need to make careful considerations when treating eyes implanted with telescopes.

Retina Today May/June 2015

Role of Mitochondrial Dysfunction in Dry Age-Related Macular Degeneration

Scott W. Cousins, MD

The site of intracellular metabolism may be a relevant drug target in dry AMD.

Retina Today May/June 2015

Use of Low-Voltage X-Ray Adjunctive to Anti-VEGF Therapy in the Treatment of Wet AMD

Aljoscha S. Neubauer, MD, MBA

Cataract & Refractive Surgery Today May 2015

Cataract Surgery in Patients With Vitreoretinal Disease

M. Ali Khan, MD; Keegan Skidmore, BA; and Allen C. Ho, MD

Prospective trials of perioperative management remain limited, but successful outcomes can be achieved.

Cataract & Refractive Surgery Today Europe May 2015

Five Pearls Every Cataract Surgeon Must Know About the Retina

Dennis P. Han, MD; and Teodoro Evans, MD

An understanding of these issues will help to ensure success in patients with retinal disease.

Cataract & Refractive Surgery Today April 2015

Five Things Every Cataract Surgeon Must Know About the Retina

Dennis P. Han, MD, and Teodoro Evans, MD

An understanding of these issues will help to ensure success in patients with retinal disease.

Cataract & Refractive Surgery Today April 2015


Cataract & Refractive Surgery Today Europe March 2015

IOL Selection for Patients With Age-Related Macular Degeneration

Meena Chakrabarti, MS; and Arup Chakrabarti, MS

The stage of disease must be considered in choosing the best lens.

Cataract & Refractive Surgery Today Europe February 2015

Sutureless Telescopic IOL for Patients With Dry AMD

Fritz H. Hengerer, MD, PhD

Implantation of the iolAMD dual lens system has been safe and effective for restoration of near and distance visual acuity in early results in eyes with intermediate dry AMD.

Retina Today January/February 2015

OCT Imaging in Eyes With an Implanted Telescope

Martha Schlimgen; Melanie J. Fortin, BS, COA; and Brian C. Joondeph, MD, MPS

Imaging of eyes implanted with the telescope presents challenges.

Cataract & Refractive Surgery Today January 2015

Telescope Implant Moves Into the ASC

Gerard D’Aversa, MD, and Glenn Stoller, MD

This change will allow more patients access.

Retina Today October 2014

Applications for Neuroprotection: The Next Therapeutic Category in Retina Medicine

Pravin U. Dugel, MD

Retina Today October 2014

Early Detection of Neovascular AMD

Michael J. Elman, MD

At-home monitoring device complements breakthroughs in the diagnosis and treatment of AMD.

Glaucoma Today September/October 2014

The Effects of Changing Demographics on Ophthalmology

Norbert Pfeiffer, MD, PhD

An increase in life expectancy means more need for eye care as the population ages.

Cataract & Refractive Surgery Today September 2014

Rethinking Cataract Surgery in Advanced AMD

Sumit “Sam” Garg, MD

A new technology may offer better outcomes in the most severely affected patients.

Retina Today July/August 2014

Long-Acting Anti-VEGF Delivery

Roman G. Rubio, MD

The potential of a posterior segment delivery system was evaluated in a phase 1 trial.

Cataract & Refractive Surgery Today June 2014

A New Approach to the Rhino in the Room

Baruch D. Kuppermann, MD, PhD

Integrin peptide therapy offers the hope of a better treatment of two of the most significant and sight-threatening conditions in ophthalmology: AMD and DME.

Cataract & Refractive Surgery Today February 2014

Toric IOLs: Broadening the Indications

Norman Saffra, MD

Patients with all degrees of AMD have been shown to benefit from cataract surgery.

Cataract & Refractive Surgery Today Europe January 2014

Macular Imaging: SD-OCT in Anterior Segment Surgical Practice

Steven G. Safran, MD

Many pathologic processes of the macula can be visualized or quantified only with this modality.

Cataract & Refractive Surgery Today Europe July/August 2013

Cataract Surgery in Compromised Eyes

Michael Amon, MD

Establish pre- and postoperative regimens to obtain optimal results in eyes with uveitis, PXF syndrome, diabetic retinopathy, and AMD.

Cataract & Refractive Surgery Today Europe July/August 2013

Protocol for Cataract Surgery in Eyes With Retinal Pathologies

Carlos Vergés, MD, PhD; and Joan Casado, MD

Successful patient preparation, meticulous surgical technique, and strict postoperative follow-up can help to achieve good outcomes.

Cataract & Refractive Surgery Today Europe November/December 2012

In the News: A Retinal Update

Callan Navitsky, Associate Editor

Recapping the newsworthy events of 2012, as originally featured in Retina Today.

Cataract & Refractive Surgery Today November/December 2012

Comanagement of Cataract and AMD: a Retinal Physician’s Perspective

Allen Chiang, MD

Cataract surgeons may want to consider a preoperative consultation with a retina colleague, even for patients with mild disease.

Cataract & Refractive Surgery Today November/December 2012

Sidebar: Screening Older Patients for Insufficient Macular Pigment Optical Density

Steven F. Sopher, OD

Cataract & Refractive Surgery Today November/December 2012

Premium Lenses and the Retina Patient

Cary M. Silverman, MD, MBA

Educate patients with retinal disease that they will not have the same outcomes as those who have no pathology.

Cataract & Refractive Surgery Today Europe February 2012

The Evolution of Posterior Segment Laser Surgery

Nancy M. Kolekamp, MD; Evangelia Papavasileiou, MD, FEBOphth; Som Prasad, MS, FRCSEd, FRCOphth, FACS; Mark R. Wieland, MD; and Jeffrey K. Luttrull, MD

The gentle art of destruction.

Cataract & Refractive Surgery Today Europe February 2012

Preoperative Assessment for Multifocal IOL Implantation

Elisabeth Patsoura, MD, MRCOphth

OCT of the posterior pole can improve outcomes.

Cataract & Refractive Surgery Today Europe November/December 2011

Nutritional Therapies to Improve Surgical Outcomes


The healing process may be shorter and more effective with proper supplementation.

Cataract & Refractive Surgery Today September 2011

AMD and Presbyopia-Correcting IOLs: What Is the Best Course of Action?


Coexisting ocular disease can reduce a multifocal IOL’s functionality.

Cataract & Refractive Surgery Today Europe May 2011

Essential Diagnostic Devices for Retina and Glaucoma Specialists


These technologies can aid in diagnosis and in developing treatment protocols.

Cataract & Refractive Surgery Today Europe February 2011

The Influence of Age on Refractive Cataract Surgery

Arthur B. Cummings, MB CHB, FCS(SA), MMED(OPHTH), FRCS(EDIN); and Richard Corkin, FCS(SA), MRCOPHTH

Patient age, lifestyle, and attitudes dictate when refractive cataract surgery is performed.

Cataract & Refractive Surgery Today Europe February 2011

FEATURE STORY: Preoperative Macular Function Testing

Steve Charels, MD; Samuel Masket, MD; JAY S. Pepose, MD, PHD; Richard Tipperman, MD; and William B. Trattler, MD

CRST Europe asked five surgeons to discuss the importance of assessing macular function in cataract patients.

Cataract & Refractive Surgery Today November 2010

Macular Function

Steve Charles, MD; Samuel Masket, MD; Jay S. Pepose, MD, PHD; Richard Tipperman, MD; and William B. Trattler, MD

Cataract & Refractive Surgery Today asked five surgeons to discuss the importance of assessing macular function in cataract patients.

Cataract & Refractive Surgery Today April 2009

Delivering Eye Care in Jamaica

Jeffrey L. Zimm, MD, Alexandra E. Zimm, Jeffrey E. Zimm, and Christian G. Zimm

Bringing state-of-the-art ophthalmic technology to this Caribbean nation is a challenging but rewarding task.


Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

Eyewire Today  |  2/22/2018

Phase 2 Data Support Potential for Novel Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody, RG7716, for People with DME

Eyewire Today  |  2/12/2018

Bausch + Lomb and Prevent Blindness Encourage People to Fight for Their Sight During February and AMD Awareness Month

Eyewire Today  |  2/6/2018

Eyepromise Introduces New Formula of Eyepromise Restore for Patients with Early Signs of AMD

Eyewire Today  |  1/30/2018

Pixium Vision Completes World’s First Successful Activation in Human of PRIMA Bionic Vision System

Eyewire Today  |  1/25/2018

Ohr Pharmaceutical Misses Primary Efficacy Endpoint in Wet-AMD Study

Eyewire Today  |  1/5/2018

LumiThera Unveils LIGHTSITE 1 Dry AMD Clinical Interim Data

Eyewire Today  |  11/8/2017

Pixium Vision Receives Approval for First-in-Human Clinical Trial of PRIMA, Its Miniaturized Sub-Retinal Implant

Eyewire Today  |  10/19/2017

Genentech Completes Patient Enrollment In Phase 2 Study Evaluating A New Delivery System for Lucentis

Eyewire Today  |  10/19/2017

PanOptica Secures Funding to Advance Clinical Development of PAN-9080 Topical Anti-VEGF Eye Drop

Eyewire Today  |  10/6/2017

Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Advance Its Retinal Disease Program

Eyewire Today  |  10/5/2017

Graybug Vision Initiates Phase 1/2 Trial of GB-102 for Wet AMD

Eyewire Today  |  9/19/2017

Genentech's Lampalizumab Fails Phase 3 Study for Geographic Atrophy

Eyewire Today  |  9/11/2017

Apellis Pharmaceuticals Announces APL-2 Met its Primary Endpoint in a Phase 2 Study in Patients with Geographic Atrophy

Eyewire Today  |  8/24/2017

New Anti-VEGF Drug Promising for Wet Macular Degeneration

Eyewire Today  |  8/16/2017

Ophthotech's Fovista Fails Third Phase 3 Trial in Wet AMD

Eyewire Today  |  8/14/2017

BioTime Announces $2 Million Grant for Further Development of OpRegen for Dry AMD

Eyewire Today  |  8/14/2017

Aerie Pharmaceuticals Enters into Collaboration with DSM Focused on Technology to Potentially Deliver Aerie Compounds to Treat Retinal Diseases

Eyewire Today  |  7/31/2017

NEI 3-D Retina Organoid Challenge (3-D ROC)

Eyewire Today  |  7/28/2017

Ophthotech Expands Focus with Development for Ophthalmic Orphan Diseases

Eyewire Today  |  7/26/2017

4D Molecular Therapeutics and Foundation Fighting Blindness Partner to Develop Gene Therapies for Retinal Diseases

Eyewire Today  |  7/25/2017

Data From BioTime’s Phase 1/2a OpRegen Trial to be Presented at the 2017 AAO Annual Meeting

Eyewire Today  |  7/19/2017

Spark Therapeutics Announces Publication of Pivotal Phase 3 Clinical Trial Data for Investigational Voretigene Neparvovec

Eyewire Today  |  7/14/2017

Nightstar Raises $45 Million to Fund Development of Gene Therapies for Blinding Retinal Diseases

Eyewire Today  |  6/30/2017

An Eye to Health: Diet and Age-Related Macular Degeneration

Eyewire Today  |  6/30/2017

Risk of Age-related Macular Degeneration Higher With Myeloproliferative Neoplasms

Eyewire Today  |  6/29/2017

MacuLogix Announces Communication Guide for Eye Care Professionals Who Diagnose and Treat AMD

Eyewire Today  |  6/28/2017

OD-OS Launches Prepanned PRP for its Navilas Laser System

Eyewire Today  |  6/27/2017

RXi Pharmaceuticals Announces Completion of Enrollment of Phase 1/2 Clinical Trial with RXI-109 for Retinal Scarring

Eyewire Today  |  6/22/2017

International Academy of Low Vision Specialists Recognizes the Mental Health Changes That May Come with a Diagnosis of AMD

Eyewire Today  |  6/21/2017

Novartis RTH258 (Brolucizumab) Demonstrates Robust Visual Gains in Wet AMD Patients with a Majority on a 12-week Injection Interval

Eyewire Today  |  6/20/2017

Aflibercept May Be Effective for Resistant Exudative AMD

Eyewire Today  |  6/15/2017

BioTime Expands Ophthalmology Portfolio With Global In-Licensing Agreement for Retinal Disease Therapy From University of Pittsburgh Medical Center

Eyewire Today  |  2/6/2017

Dexamethasone Implant With Anti-VEGF Explored for Wet AMD

Eyewire Today  |  2/3/2017

Genentech Completes Patient Enrollment in Two Large Phase 3 Studies for Lampalizumab

Eyewire Today  |  2/2/2017

Ophthotech Announces Strategic Review Plan

Eyewire Today  |  2/1/2017

Lucentis 0.5 mg Prefilled Syringe Now Available to Order in the US

Eyewire Today  |  1/30/2017

ForSight Vision 4 Announces Acquisition by Roche

Eyewire Today  |  1/13/2017

FDA Grants "Safe to Proceed" Status to Hemera Biosciences' Gene Therapy IND Application

Eyewire Today  |  1/12/2017

Acucela Receives Orphan Drug Designation from the FDA for the Treatment of Stargardt Disease

Eyewire Today  |  1/6/2017

Lin Bioscience Licenses First-in-Class Therapeutic Program to Treat Dry AMD from Columbia University in Collaboration with NIH

Eyewire Today  |  1/6/2017

Acucela Secures Option to Exclusively Acquire Novel Retinal Technology

Eyewire Today  |  12/14/2016